Jefferies Group LLC Analysts Set Monsanto Company (MON) a $128.00 Target Price

Jefferies Group LLC Analysts Set Monsanto Company (MON) a $128.00 Target Price

Monsanto Company (NYSE:MON) has been given a $128.00 price target by Jefferies Group LLC in a research report issued on Tuesday. The brokerage presently has a “buy” rating on the stock. Jefferies Group LLC’s target price indicates a potential upside of 12.19% from the stock’s previous close.

Several other equities analysts also recently issued reports on the stock. Vetr raised shares of Monsanto Company from a “hold” rating to a “buy” rating and set a $118.00 price objective on the stock in a report on Wednesday, March 15th. CLSA raised shares of Monsanto Company from an “underperform” rating to an “outperform” rating in a report on Friday, January 6th. They noted that the move was a valuation call. Zacks Investment Research raised shares of Monsanto Company from a “hold” rating to a “buy” rating and set a $122.00 price objective on the stock in a report on Tuesday, January 10th. Royal Bank of Canada initiated coverage on shares of Monsanto Company in a report on Thursday, February 23rd. They set a “sector perform” rating and a $118.00 price objective on the stock. Finally, Sanford C. Bernstein set a $105.00 price objective on shares of Monsanto Company and gave the company a “neutral” rating in a report on Thursday, January 5th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and fifteen have issued a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $115.95.

Shares of Monsanto Company (NYSE:MON) traded up 0.10% during trading on Tuesday, reaching $114.20. 1,040,265 shares of the company traded hands. Monsanto Company has a 52 week low of $84.79 and a 52 week high of $116.04. The firm has a 50 day moving average of $111.98 and a 200 day moving average of $106.06. The stock has a market capitalization of $50.08 billion, a PE ratio of 31.31 and a beta of 0.93.

Monsanto Company (NYSE:MON) last posted its quarterly earnings data on Thursday, January 5th. The company reported $0.21 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.01 by $0.20. The business had revenue of $2.22 billion for the quarter. Monsanto Company had a net margin of 11.61% and a return on equity of 47.05%. The business’s revenue for the quarter was up 19.4% on a year-over-year basis. During the same period in the previous year, the business earned ($0.11) earnings per share. On average, equities analysts predict that Monsanto Company will post $4.74 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 28th. Investors of record on Friday, April 7th will be issued a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.89%. The ex-dividend date is Wednesday, April 5th. Monsanto Company’s dividend payout ratio (DPR) is currently 58.86%.

In related news, CEO Michael K. Stern sold 5,670 shares of Monsanto Company stock in a transaction that occurred on Wednesday, January 25th. The shares were sold at an average price of $110.00, for a total value of $623,700.00. Following the completion of the transaction, the chief executive officer now owns 20,534 shares in the company, valued at $2,258,740. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Steven Mizell sold 2,525 shares of Monsanto Company stock in a transaction that occurred on Tuesday, January 10th. The stock was sold at an average price of $108.56, for a total transaction of $274,114.00. Following the completion of the transaction, the executive vice president now owns 43,711 shares of the company’s stock, valued at approximately $4,745,266.16. The disclosure for this sale can be found here. Insiders own 0.79% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the company. Strs Ohio increased its position in shares of Monsanto Company by 4.3% in the third quarter. Strs Ohio now owns 285,114 shares of the company’s stock worth $29,138,000 after buying an additional 11,861 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. increased its position in shares of Monsanto Company by 30.7% in the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,619,635 shares of the company’s stock worth $165,527,000 after buying an additional 379,975 shares in the last quarter. Meridian Management Co. increased its stake in shares of Monsanto Company by 0.5% in the third quarter. Meridian Management Co. now owns 22,003 shares of the company’s stock valued at $2,249,000 after buying an additional 103 shares in the last quarter. BlackRock Japan Co. Ltd increased its stake in shares of Monsanto Company by 2.6% in the third quarter. BlackRock Japan Co. Ltd now owns 569,118 shares of the company’s stock valued at $58,164,000 after buying an additional 14,518 shares in the last quarter. Finally, Country Trust Bank increased its stake in shares of Monsanto Company by 71.6% in the third quarter. Country Trust Bank now owns 221,268 shares of the company’s stock valued at $22,614,000 after buying an additional 92,302 shares in the last quarter. Institutional investors own 75.18% of the company’s stock.

Monsanto Company Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Related posts

Leave a Comment